MLICM
ADPT icon

Metropolitan Life Insurance Company (MetLife)’s Adaptive Biotechnologies ADPT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,808
Closed -$12.2K – 50
2024
Q1 		$12.2K Sell
3,808
-3,415
-47% -$13.2K ﹤0.01% 2060
2023
Q4 		$35.4K Hold
7,223
– – ﹤0.01% 1625
2023
Q3 		$39.4K Buy
7,223
+1,098
+18% +$7.26K ﹤0.01% 1537
2023
Q2 		$41.1K Buy
6,125
+819
+15% +$6.09K ﹤0.01% 1540
2023
Q1 		$46.9K Sell
5,306
-1,456
-22% -$12.8K ﹤0.01% 1424
2022
Q4 		$51.7K Hold
6,762
– – ﹤0.01% 1452
2022
Q3 		$48.1K Hold
6,762
– – ﹤0.01% 1481
2022
Q2 		$54.7K Buy
+6,762
New +$59.5K ﹤0.01% 1445
2022
Q1 		– Sell
-6,686
Closed -$188K – 2249
2021
Q4 		$188K Sell
6,686
-49
-0.7% -$1.5K ﹤0.01% 2073
2021
Q3 		$229K Sell
6,735
-224
-3% -$8.1K ﹤0.01% 1970
2021
Q2 		$284K Buy
6,959
+1,419
+26% +$55.2K ﹤0.01% 1897
2021
Q1 		$223K Sell
5,540
-249
-4% -$13.5K ﹤0.01% 1941
2020
Q4 		$342K Sell
5,789
-113
-2% -$5.83K 0.01% 1608
2020
Q3 		$287K Buy
5,902
+252
+4% +$10.6K ﹤0.01% 1569
2020
Q2 		$273K Buy
5,650
+1,861
+49% +$67.9K ﹤0.01% 1607
2020
Q1 		$105K Buy
3,789
+2,830
+295% +$78.9K ﹤0.01% 2000
2019
Q4 		$28.7K Sell
959
-15
-2% -$431 ﹤0.01% 2513
2019
Q3 		$30.1K Buy
+974
New +$39.8K ﹤0.01% 2533

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ADPT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Adaptive Biotechnologies (ADPT) in Q2 2024, closing a stake of 3,808 shares — an estimated $12.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ADPT in Q3 2019 and held it in 18 quarters. The position peaked at $342K in Q4 2020. 176 funds tracked by Wall St. Rank hold ADPT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Adaptive Biotechnologies position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,808 Adaptive Biotechnologies shares in Q2 2024, an estimated $12.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Adaptive Biotechnologies in Q3 2019 and held it in 18 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Adaptive Biotechnologies position peaked at $342K in Q4 2020.
  • 176 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.